GUANACLINE SULFATE ANHYDROUS

OS(O)(=O)=O.CC1=CCN(CCNC(N)=N)CC1

InChIKey=FLZPKJNDZPCKJG-UHFFFAOYSA-N

InChI=1S/C9H18N4.H2O4S/c1-8-2-5-13(6-3-8)7-4-12-9(10)11;1-5(2,3)4/h2H,3-7H2,1H3,(H4,10,11,12);(H2,1,2,3,4)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Guanacline was studied in the treatment of hypertension. However, information about the current use of this compound is not available.

PubMed

Title	Date	PubMed
Species and structural specificity of the lipopigment accumulation and neuronal destruction induced by N-(2-guanidinoethyl)-4-methyl-1,2,5,6-tetrahydropyridine (guanacline).	1986-09-24	3768685
Clinical experiences with Leron (guanacline) in the treatment of hypertension.	1970-05-09	5420832
Guanacline, a new hypotensive drug.	1969-01-25	5779041

Substance Class	Chemical Created by `admin` on `Mon Mar 31 17:45:53 GMT 2025` Edited by `admin` on `Mon Mar 31 17:45:53 GMT 2025`
Record UNII	UE69UT7F2Y
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

GUANACLINE SULFATE ANHYDROUS

Common Name

English

GUANACLINE MONOSULFATE [MI]

Preferred Name

English

GUANACLINE SULPHATE ANHYDROUS

Common Name

English

Guanacline sulfate anhydrous [WHO-DD]

Common Name

English

Code System Code Type Description

ECHA (EC/EINECS)

216-344-1